Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study.

MLA

Fichna, Jakub, et al. “Endocannabinoid and Cannabinoid-like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study.” PloS One, vol. 8, no. 12, Dec. 2013, p. e85073. EBSCOhost, https://doi.org/10.1371/journal.pone.0085073.

APA

Fichna, J., Wood, J. T., Papanastasiou, M., Vadivel, S. K., Oprocha, P., Sałaga, M., Sobczak, M., Mokrowiecka, A., Cygankiewicz, A. I., Zakrzewski, P. K., Małecka-Panas, E., Krajewska, W. M., Kościelniak, P., Makriyannis, A., & Storr, M. A. (2013). Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study. PloS One, 8(12), e85073. https://doi.org/10.1371/journal.pone.0085073

Chicago

Fichna, Jakub, Jodianne T Wood, Malvina Papanastasiou, Subramanian K Vadivel, Piotr Oprocha, Maciej Sałaga, Marta Sobczak, et al. 2013. “Endocannabinoid and Cannabinoid-like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study.” PloS One 8 (12): e85073. doi:10.1371/journal.pone.0085073.